25-Aug-2021

Active Pharmaceutical Ingredients (API) Market Overview, COVID-19 Impact Analysis, Technological Innovations with Economic Indicators By 2028

Active Pharmaceutical Ingredients (API) Market document sheds lamp on market size, regional changing trends, emerging new prospects for market growth rate, and production value estimation from 2021 – 2027. This market research report is a painstaking investigation of the current scenario of the market and future estimations which covers several market dynamics. The report serves the analysis of the global market share, segmentation, revenue growth estimation, and geographic regions of the market. The report is a great resource, which provides current and upcoming technical and financial details of the industry. This market analysis report provides top to bottom analysis and estimation of various market-related factors that play a key role in better decision making.

The active pharmaceutical ingredients (API) market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.1% in the forecast period of 2021 to 2028 and is expected to reach USD 300,722.26 million by 2028. Increasing prevalence of various chronic disorders and increase in aging population are the major drivers which propelled the demand of the active pharmaceutical ingredients (API) market in the forecast period.

Get a Sample Copy of the Report to comprehend the construction of the total report (Including Full TOC, Table, and Figures): https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-active-pharmaceutical-ingredient-api-market

Global Active Pharmaceutical Ingredients (API) Market Scenario

According to Data Bridge Market Research, the market for active pharmaceutical ingredients (API) in North America has the highest market share followed by Europe and Asia-Pacific. Market leader is Teva Pharmaceuticals Industries Ltd. which accounts an estimated market share of approximately 1% to 2% globally. The company has gained appreciation and acquisition to develop innovative treatment for the active pharmaceutical ingredients (API) to the market.

In November 2020, Teva Pharmaceuticals Industries Ltd. had received EcoVadis Silver Medal. The company was awarded due to the best responsibilities regarding environment, labor and human rights practices, ethics and sustainable procurement. EcoVadis award is given to the company according to the company’s global supply chain rating. This award helped the company to get recognized through their supply chains of their products.

Key Market Competitors Covered in the Report:

Dr. Reddy’s Laboratories Ltd.
Sun Pharmaceutical Industries Ltd.
Pfizer Inc.
Sanofi
GlaxoSmithKline plc
AARTI INDUSTRIES LIMITED
Recipharm AB
Jubilant Pharmova Limited
LUPIN
Aurobindo Pharma
Alembic Pharmaceuticals Limited
AbbVie Inc.
AstraZeneca
Alkem Labs
Albemarle Corporation
Saneca Pharmaceuticals
Unichem Laboratories
Neuland Laboratories Ltd.
Divi’s Laboratories Limited
HIKAL Ltd.
Viatris Inc.
Merck KGaA
Novo Nordisk A/S
Sandoz International GmbH (a subsidiary of Novartis AG)
Teva Pharmaceutical Industries Ltd.
Minakem
BASF SE
Cipla Inc.
CordenPharma International
Piramal Pharma Solutions

Get the Latest TOC Of This Report @ https://www.databridgemarketresearch.com/toc/?dbmr=global-active-pharmaceutical-ingredient-api-market

New Market Development

In October 2020, CordenPharma International had announced the completion of the highly potent API laboratory which is situated in Boulder, Colorado. The new laboratory in Colorado will be involved in the manufacturing and commercialization of the APIs and the motive of the company were to meet the customers demand. This has helped the company to enhance their product portfolio in the field of the APIs and increase their revenues in coming future.

Scope of the Global Active Pharmaceutical Ingredients (API) Market

Global active pharmaceutical ingredients (API) market is segmented on the basis of countries into the U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, rest of Europe, Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, rest of Asia-Pacific, Brazil, Argentina, Peru, rest of South America, Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt and rest of Middle East and Africa.

All country based analysis of the global active pharmaceutical ingredients (API) market is further analyzed based on maximum granularity into further segmentation. On the basis of molecule, the active pharmaceutical ingredients (API) market is segmented into small molecule and large molecule. On the basis of type, the active pharmaceutical ingredients (API) market is segmented into innovative active pharmaceutical ingredients and generic active pharmaceutical ingredients. On the basis of type of manufacturer, the active pharmaceutical ingredients (API) market is segmented into captive API manufacturer and merchant API manufacturer. On the basis of synthesis, the active pharmaceutical ingredients (API) market is segmented into synthetic active pharmaceutical ingredients and biotech active pharmaceutical ingredients. On the basis of chemical synthesis, the active pharmaceutical ingredients (API) market is segmented into acetaminophen, artemisinin, saxagliptin, sodium chloride, ibuprofen losartan potassium, enoxaparin sodium, rufinamide, naproxen, tamoxifen and others. On the basis of type of drug, the active pharmaceutical ingredients (API) market is segmented into prescription drugs and over-the-counter drugs. On the basis of usage, the active pharmaceutical ingredients (API) market is segmented into clinical and research. On the basis of potency, the active pharmaceutical ingredients (API) market is segmented into low-to-moderate potency active pharmaceutical ingredients and potent-to-highly potent active pharmaceutical ingredient. On the basis of therapeutic application, the active pharmaceutical ingredients (API) market is segmented into cardiology, CNS & neurology, oncology, orthopedic, endocrinology, pulmonology, gastroenterology, nephrology, ophthalmology and other therapeutic application.

By Region

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, and Italy)

Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)

South America (Brazil, Argentina, Colombia, etc.)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

List of Figures:

FIGURE 1 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET: SEGMENTATION

FIGURE 2 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET: DATA TRIANGULATION

FIGURE 3 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET: DROC ANALYSIS

FIGURE 4 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS

FIGURE 5 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET: MULTIVARIATE MODELLING

FIGURE 7 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET: DBMR MARKET POSITION GRID

FIGURE 9 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET: MARKET TYPE OF MANUFACTURER COVERAGE GRID

FIGURE 11 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET: SEGMENTATION

FIGURE 12 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 UTILIZATION OF ADVANCED TECHNOLOGY IN ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING IS DRIVING THE GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 14 SMALL MOLECULE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET IN 2021 & 2028

FIGURE 15 NORTH AMERICA IS THE FASTEST GROWING MARKET FOR THE ACTIVE PHARMACEUTICAL INGREDIENTS (API) MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET

FIGURE 17 NUMBER OF PERSONS AGED 60 YEARS ACROSS SEVERAL REGIONS IN 2017 AND 2050

FIGURE 18 HEALTHCARE EXPENDITURE PER CAPITA

FIGURE 19 SHARE OF API MARKET OCCUPIED IN ASIA

FIGURE 20 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET: BY MOLECULE, 2021

FIGURE 21 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET: BY MOLECULE, 2017-2028 (USD MILLION)

FIGURE 22 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET: BY MOLECULE, CAGR (2021-2028)

FIGURE 23 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET: BY MOLECULE, LIFELINE CURVE

FIGURE 1 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET: BY TYPE, 2021

FIGURE 2 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET: BY TYPE, 2017-2028 (USD MILLION)

FIGURE 3 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET: BY TYPE, CAGR (2021-2028)

FIGURE 4 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET: BY TYPE, LIFELINE CURVE

FIGURE 5 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET: BY TYPE OF MANUFACTURERS, 2021

FIGURE 6 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET: BY TYPE OF MANUFACTURERS, 2017-2028 (USD MILLION)

FIGURE 7 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET: BY TYPE OF MANUFACTURERS, CAGR (2021-2028)

FIGURE 8 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET: BY TYPE OF MANUFACTURERS, LIFELINE CURVE

FIGURE 9 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET: BY SYNTHESIS, 2021

FIGURE 10 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET: BY SYNTHESIS, 2017-2028 (USD MILLION)

FIGURE 11 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET: BY SYNTHESIS, CAGR (2021-2028)

FIGURE 12 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET: BY SYNTHESIS, LIFELINE CURVE

FIGURE 13 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET: BY CHEMICAL SYNTHESIS, 2021

FIGURE 14 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET: BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)

FIGURE 15 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET: BY CHEMICAL SYNTHESIS, CAGR (2021-2028)

——

Get More Information on this Research Report: https://www.databridgemarketresearch.com/reports/global-active-pharmaceutical-ingredient-api-market

Key Offerings:

– Market Size and Forecast by Revenue | 2021−2028
– Market Dynamics – Leading patterns, development drivers, limitations, and venture openings
– Market Segmentation – An itemized examination by item, by types, end-client, applications, fragments, and geology
– Competitive Landscape – Top key sellers and other conspicuous vendorsInquire

Research Methodology: Global Active Pharmaceutical Ingredients (API) Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Manufacturers, Healthcare Industry, Scientists and Research Laboratories
Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence and Regulatory Affairs Managers among others

Related Reports

About Data Bridge Market Research

An absolute way to forecast what the future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process.

Data Bridge is adept at creating satisfied clients who rely on our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Corporatesales@databridgemarketresearch.com

Editor Details

Company:
- The Wire Times

Last Updated: 25-Aug-2021